Webinar on COVID-19 and diabetes
About 10% of coronavirus-infected patients have diabetes as a comorbidity. It seems diabetes may not increase the risk of SARS-CoV-2 infection, but it promotes severe progression of disease in COVID-19 patients. Diabetes promotes severe progression in COVID-19 patients. Diabetes comorbidity is associated with significantly increased mortality (0.9% mortality for patients without comorbidity vs. 7.3% mortality for patients with diabetes) Diabetes with COVID-19 appears more blood glucose fluctuations, strengthen dynamic glucose monitoring is necessary Insulin IV injection should be the first-line treatment in severe and critical patients.
Diabetes mellitus, , COVID-19 , Management , Patients , Research Subject Categories::MEDICINE
Fasanmade OA. Webinar on COVID-19 and diabetes. 2020